Valiant Laboratories Limited (VALIANTLAB.BO)

INR 127.0

(13.54%)

EBITDA Summary of Valiant Laboratories Limited

  • Valiant Laboratories Limited's latest annual EBITDA in 2023 was 12.73 Million INR , down -123.14% from previous year.
  • Valiant Laboratories Limited's latest quarterly EBITDA in 2024 Q1 was -23.88 Million INR , up 120.99% from previous quarter.
  • Valiant Laboratories Limited reported an annual EBITDA of 399.53 Million INR in 2022, down -18.1% from previous year.
  • Valiant Laboratories Limited reported an annual EBITDA of 442.67 Million INR in 2021, down -13.71% from previous year.
  • Valiant Laboratories Limited reported a quarterly EBITDA of 38.15 Million INR for 2023 Q1, down -55.8% from previous quarter.
  • Valiant Laboratories Limited reported a quarterly EBITDA of -45.3 Million INR for 2023 Q4, up 0.03% from previous quarter.

Annual EBITDA Chart of Valiant Laboratories Limited (2023 - 2020)

Historical Annual EBITDA of Valiant Laboratories Limited (2023 - 2020)

Year EBITDA EBITDA Growth
2023 12.73 Million INR -123.14%
2022 399.53 Million INR -18.1%
2021 442.67 Million INR -13.71%
2020 514.14 Million INR 0.0%

Peer EBITDA Comparison of Valiant Laboratories Limited

Name EBITDA EBITDA Difference
Ajanta Pharma Limited 12.56 Billion INR 99.899%
Amrutanjan Health Care Limited 682.53 Million INR 98.134%
Sigachi Industries Limited 883.39 Million INR 98.558%
Bal Pharma Limited 345.59 Million INR 96.314%
Ind-Swift Laboratories Limited 6.86 Billion INR 99.814%
Medico Remedies Limited 150.37 Million INR 91.529%
Lasa Supergenerics Limited -65.08 Million INR 119.574%
Venus Remedies Limited 711.8 Million INR 98.21%
Sun Pharma Advanced Research Company Limited -3.73 Billion INR 100.341%
Alpa Laboratories Limited 86.12 Million INR 85.209%
Nectar Lifesciences Limited 1.56 Billion INR 99.185%
Shilpa Medicare Limited 2.58 Billion INR 99.508%
Aarti Drugs Limited 3.24 Billion INR 99.608%
Lupin Limited 36.96 Billion INR 99.966%
Aurobindo Pharma Limited 61.78 Billion INR 99.979%
Zydus Lifesciences Limited 56.22 Billion INR 99.977%
Windlas Biotech Limited 781.72 Million INR 98.37%
Suven Life Sciences Limited -992.78 Million INR 101.283%
Eris Lifesciences Limited 6.98 Billion INR 99.818%
J. B. Chemicals & Pharmaceuticals Limited 9.33 Billion INR 99.864%
Solara Active Pharma Sciences Limited -2.82 Billion INR 100.451%
Ipca Laboratories Limited 13.29 Billion INR 99.904%
Bliss GVS Pharma Limited 1.47 Billion INR 99.139%
Achyut Healthcare Limited 524 Thousand INR -2331.107%
Sun Pharmaceutical Industries Limited 138.36 Billion INR 99.991%
Bajaj HealthCare Limited 444.51 Million INR 97.134%
RPG Life Sciences Limited 1.28 Billion INR 99.006%
Mankind Pharma Limited 28.09 Billion INR 99.955%
Laurus Labs Limited 8 Billion INR 99.841%
Piramal Pharma Limited 13.05 Billion INR 99.902%
Syncom Formulations (India) Limited 430.27 Million INR 97.039%
Torrent Pharmaceuticals Limited 35 Billion INR 99.964%
Alembic Pharmaceuticals Limited 9.61 Billion INR 99.868%
Glenmark Pharmaceuticals Limited 11.34 Billion INR 99.888%
Unichem Laboratories Limited 742.35 Million INR 98.284%
Sequent Scientific Limited 549.8 Million INR 97.683%
Novartis India Limited 1.26 Billion INR 98.996%
Wanbury Limited 985.49 Million INR 98.707%
Suven Pharmaceuticals Limited 4.67 Billion INR 99.728%
Wockhardt Limited 1.08 Billion INR 98.82%
Themis Medicare Limited 562.6 Million INR 97.736%
Jagsonpal Pharmaceuticals Limited 323.46 Million INR 96.062%
Jubilant Pharmova Limited 8 Billion INR 99.841%
Glenmark Life Sciences Limited 6.86 Billion INR 99.814%
Dr. Reddy's Laboratories Limited 88.27 Billion INR 99.986%
Divi's Laboratories Limited 25.43 Billion INR 99.95%
NATCO Pharma Limited 18.79 Billion INR 99.932%
Gufic Biosciences Limited 1.48 Billion INR 99.14%
IOL Chemicals and Pharmaceuticals Limited 2.6 Billion INR 99.511%
Ind-Swift Limited 1.06 Billion INR 98.804%
Procter & Gamble Health Limited 3.01 Billion INR 99.577%
FDC Limited 4.4 Billion INR 99.711%
Krebs Biochemicals & Industries Limited -82.72 Million INR 115.399%
Granules India Limited 8.6 Billion INR 99.852%
Medicamen Biotech Limited 245.66 Million INR 94.814%
Alkem Laboratories Limited 24.19 Billion INR 99.947%
AstraZeneca Pharma India Limited 2.35 Billion INR 99.459%
Biofil Chemicals and Pharmaceuticals Limited 13.06 Million INR 2.473%
Brooks Laboratories Limited 41.72 Million INR 69.471%
Megasoft Limited 284.73 Million INR 95.526%
ZIM Laboratories Limited 462.09 Million INR 97.243%
Strides Pharma Science Limited 3.76 Billion INR 99.662%
Neuland Laboratories Limited 4.74 Billion INR 99.732%
Morepen Laboratories Limited 1.72 Billion INR 99.262%
Hikal Limited 2.69 Billion INR 99.527%
Indoco Remedies Limited 2.64 Billion INR 99.519%
Aarti Pharmalabs Limited 3.9 Billion INR 99.674%
Kilitch Drugs (India) Limited 287.42 Million INR 95.568%
Mangalam Drugs & Organics Limited 174.94 Million INR 92.718%
Hester Biosciences Limited 539.47 Million INR 97.639%